ID: ALA4066164

Max Phase: Preclinical

Molecular Formula: C29H29N3O3

Molecular Weight: 467.57

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1/C(=N/OCCc2ccccc2)[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46

Standard InChI:  InChI=1S/C29H29N3O3/c33-28-25(30-35-15-10-18-6-2-1-3-7-18)26-24-20-16-23-29(12-13-31(23)17-19(20)11-14-34-26)21-8-4-5-9-22(21)32(28)27(24)29/h1-9,11,20,23-24,26-27H,10,12-17H2/b30-25+/t20-,23-,24-,26+,27-,29+/m0/s1

Standard InChI Key:  AOUHSICIWMGARK-ICMABZSESA-N

Associated Targets(Human)

Glycine receptor (alpha-1/beta) 119 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glycine receptor subunit alpha-1 392 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 467.57Molecular Weight (Monoisotopic): 467.2209AlogP: 3.32#Rotatable Bonds: 4
Polar Surface Area: 54.37Molecular Species: BASEHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.30CX LogP: 3.53CX LogD: 1.64
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.39Np Likeness Score: 1.81

References

1. Mohsen AM, Mandour YM, Sarukhanyan E, Breitinger U, Villmann C, Banoub MM, Breitinger HG, Dandekar T, Holzgrabe U, Sotriffer C, Jensen AA, Zlotos DP..  (2016)  Oxime Ethers of (E)-11-Isonitrosostrychnine as Highly Potent Glycine Receptor Antagonists.,  79  (12): [PMID:27966945] [10.1021/acs.jnatprod.6b00479]

Source